These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37277196)

  • 41. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Geographical and practical challenges in the implementation of digital health passports for cross-border COVID-19 pandemic management: a narrative review and framework for solutions.
    Towett G; Snead RS; Grigoryan K; Marczika J
    Global Health; 2023 Dec; 19(1):98. PubMed ID: 38066568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
    Privor-Dumm LA; Poland GA; Barratt J; Durrheim DN; Deloria Knoll M; Vasudevan P; Jit M; Bonvehí PE; Bonanni P;
    Vaccine; 2021 Aug; 39(37):5240-5250. PubMed ID: 32703743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccines for neglected, emerging and re-emerging diseases.
    Madhav A; Mehrotra T; Sinha P; Mutreja A
    Semin Immunol; 2020 Aug; 50():101423. PubMed ID: 33250352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives.
    Saied AA; Metwally AA; Dhawan M; Choudhary OP; Aiash H
    EMBO Mol Med; 2022 Aug; 14(8):e16287. PubMed ID: 35758210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People.
    Garbuglia AR; Minosse C; Del Porto P
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thoughts and suggestions on co-administration of seasonal influenza vaccine and COVID-19 vaccine].
    Kou ZQ; Liu LJ; Xu CS; Zhao HT; Zhang ZN; Yang XK; Peng ZB; Feng LZ; Xu AQ; Wang DY; Chen ZP; Zheng JD; Feng ZJ; Yu WZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1395-1400. PubMed ID: 36274604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 vaccine and pregnancy: A safety weapon against pandemic.
    Magon N; Prasad S; Mahato C; Sharma JB
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):201-209. PubMed ID: 35361377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 vaccine candidates in rapid development.
    Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
    Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "No Regrets" Purchasing in a pandemic: making the most of advance purchase agreements.
    Thornton I; Wilson P; Gandhi G
    Global Health; 2022 Jun; 18(1):62. PubMed ID: 35715814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics.
    Martin R; Maleche A; Gay J; Fatima H
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38167259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical development and approval of COVID-19 vaccines.
    Kalinke U; Barouch DH; Rizzi R; Lagkadinou E; Türeci Ö; Pather S; Neels P
    Expert Rev Vaccines; 2022 May; 21(5):609-619. PubMed ID: 35157542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016).
    Palkonyay L; Fatima H
    Vaccine; 2016 Oct; 34(45):5414-5419. PubMed ID: 27498212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thinking on your feet: Beauty and auto small businesses maneuver the risks of the COVID-19 pandemic.
    Moreno Ramírez D; Gutenkunst S; Honan J; Ingram M; Quijada C; Chaires M; Sneed SJ; Sandoval F; Spitz R; Carvajal S; Billheimer D; Wolf AM; Beamer PI
    Front Public Health; 2022; 10():921704. PubMed ID: 36106169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.
    Fuller A; Hancox J; Vedhara K; Card T; Mallen C; Van-Tam JSN; Abhishek A
    PLoS One; 2022; 17(9):e0267769. PubMed ID: 36084032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group.
    Chandler RE; Balakrishnan MR; Brasseur D; Bryan P; Espie E; Hartmann K; Jouquelet-Royer C; Milligan J; Nesbitt L; Pal S; Precioso A; Takey P; Chen RT;
    BMJ Glob Health; 2024 Mar; 9(3):. PubMed ID: 38453518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines.
    Williams SR; Driscoll AJ; LeBuhn HM; Chen WH; Neuzil KM; Ortiz JR
    Euro Surveill; 2021 Apr; 26(17):. PubMed ID: 33928899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Doerfler W
    Virus Res; 2021 Sep; 302():198466. PubMed ID: 34087261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.
    Chukwu OA; Kapiriri L; Essue B
    Int J Pharm Pract; 2022 Jun; 30(3):284-287. PubMed ID: 35468198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.